Suli Dai

595 total citations
28 papers, 413 citations indexed

About

Suli Dai is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Suli Dai has authored 28 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Suli Dai's work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (10 papers) and Phytochemistry and Bioactive Compounds (5 papers). Suli Dai is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (10 papers) and Phytochemistry and Bioactive Compounds (5 papers). Suli Dai collaborates with scholars based in China, France and United States. Suli Dai's co-authors include Lianmei Zhao, Baoen Shan, Sisi Wei, Xiaoya Li, Cong Zhang, Cong Zhang, Lianmei Zhao, Haixia Ding, Lei Li and Baoen Shan and has published in prestigious journals such as Advanced Science, Carcinogenesis and BioMed Research International.

In The Last Decade

Suli Dai

25 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suli Dai China 12 291 183 93 82 42 28 413
Feizhou Jiang China 10 328 1.1× 218 1.2× 99 1.1× 106 1.3× 22 0.5× 18 508
Abdullah Moridikia Iran 7 362 1.2× 281 1.5× 68 0.7× 73 0.9× 16 0.4× 8 547
Lile He China 10 269 0.9× 190 1.0× 63 0.7× 94 1.1× 16 0.4× 18 432
Suan Sun China 12 268 0.9× 197 1.1× 34 0.4× 75 0.9× 29 0.7× 24 403
Izabela Sacewicz‐Hofman Poland 10 217 0.7× 116 0.6× 69 0.7× 105 1.3× 12 0.3× 14 397
Dongli Zhao China 10 241 0.8× 154 0.8× 33 0.4× 59 0.7× 14 0.3× 21 350
Jiantao Xiao China 12 221 0.8× 72 0.4× 38 0.4× 66 0.8× 32 0.8× 16 367
Ching‐Wen Lin Taiwan 6 461 1.6× 423 2.3× 63 0.7× 59 0.7× 12 0.3× 10 662
Siyang Dong China 12 295 1.0× 195 1.1× 27 0.3× 87 1.1× 14 0.3× 18 494
Weijie Dai China 13 275 0.9× 183 1.0× 30 0.3× 42 0.5× 17 0.4× 27 359

Countries citing papers authored by Suli Dai

Since Specialization
Citations

This map shows the geographic impact of Suli Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suli Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suli Dai more than expected).

Fields of papers citing papers by Suli Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suli Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suli Dai. The network helps show where Suli Dai may publish in the future.

Co-authorship network of co-authors of Suli Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Suli Dai. A scholar is included among the top collaborators of Suli Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suli Dai. Suli Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Xiaojian, Yan Xi, Sisi Wei, et al.. (2025). GRHL3 specifically initiated by the TP63 transcription factor promotes the metastasis of squamous cell carcinogenesis. Cellular Signalling. 132. 111794–111794.
2.
Wei, Sisi, Chunhong Feng, Zhe Zhang, et al.. (2025). IFI30 Knockdown Inhibits ESCC Progression by Promoting Apoptosis and Senescence via Activation of JNK and P21/P16 Pathways. Thoracic Cancer. 16(7). e70063–e70063.
3.
Wei, Sisi, Xinyi Fan, Xiaoya Li, et al.. (2024). Hypoxia Induced Lnc191 Upregulation Dictates the Progression of Esophageal Squamous Cell Carcinoma by Activating GRP78/ERK Pathway. Advanced Science. 12(4). e2406674–e2406674.
4.
Wang, Yaojie, Sisi Wei, Suli Dai, et al.. (2024). NEK2 Promotes ESCC Malignant Progression by Inhibiting Cellular Senescence via the FOXM1/c‐Myc/p27 Signaling Pathway. Molecular Carcinogenesis. 64(2). 244–259. 1 indexed citations
5.
Wei, Sisi, Suli Dai, Xiaoya Li, et al.. (2023). The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development. Journal for ImmunoTherapy of Cancer. 11(5). e006230–e006230. 42 indexed citations
6.
7.
8.
Zhang, Cong, Huixia Wang, Qingwei Liu, et al.. (2023). LncRNA CCAT1 facilitates the progression of gastric cancer via PTBP1-mediated glycolysis enhancement. Journal of Experimental & Clinical Cancer Research. 42(1). 246–246. 34 indexed citations
9.
Dong, Yang, et al.. (2022). ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma. BioMed Research International. 2022(1). 5328192–5328192. 10 indexed citations
10.
Huang, Ying, et al.. (2022). Flotillin-1 promotes EMT of gastric cancer via stabilizing Snail. PeerJ. 10. e13901–e13901. 8 indexed citations
11.
Wei, Sisi, Xiaoya Li, Jingjing Wang, et al.. (2021). Outer Membrane Vesicles Secreted by Helicobacter pylori Transmitting Gastric Pathogenic Virulence Factors. ACS Omega. 7(1). 240–258. 25 indexed citations
12.
Chen, Han, Suli Dai, Sisi Wei, et al.. (2021). Inhibitory Effects of Periplocin on Lymphoma Cells: A Network Pharmacology Approach and Experimental Validation. Drug Design Development and Therapy. Volume 15. 1333–1344. 3 indexed citations
13.
Cheng, Yi, Guiying Wang, Lianmei Zhao, et al.. (2021). Periplocymarin Induced Colorectal Cancer Cells Apoptosis Via Impairing PI3K/AKT Pathway. Frontiers in Oncology. 11. 753598–753598. 21 indexed citations
14.
Wei, Sisi, Suli Dai, Cong Zhang, et al.. (2021). LncRNA NR038975, A Serum-Based Biomarker, Promotes Gastric Tumorigenesis by Interacting With NF90/NF45 Complex. Frontiers in Oncology. 11. 721604–721604. 10 indexed citations
15.
Wei, Sisi, Suli Dai, Cong Zhang, et al.. (2021). SNORA42 promotes oesophageal squamous cell carcinoma development through triggering the DHX9/p65 axis. Genomics. 113(5). 3015–3029. 10 indexed citations
16.
Wei, Sisi, Xinliang Zhou, Cong Zhang, et al.. (2020). SNHG5 inhibits the progression of EMT through the ubiquitin-degradation of MTA2 in oesophageal cancer. Carcinogenesis. 42(2). 315–326. 17 indexed citations
17.
Dai, Suli, Zhirong Li, Cong Zhang, et al.. (2019). Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. Journal of Experimental & Clinical Cancer Research. 38(1). 501–501. 28 indexed citations
18.
19.
Zhang, Cong, Lianmei Zhao, Hao Wu, et al.. (2018). C/D-Box Snord105b Promotes Tumorigenesis in Gastric Cancer via ALDOA/C-Myc Pathway. Cellular Physiology and Biochemistry. 45(6). 2471–2482. 23 indexed citations
20.
Ding, Haixia, et al.. (2015). CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer. Biomedicine & Pharmacotherapy. 77. 142–149. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Feizhou Jiang Breakdown of academic impact, for papers by Abdullah Moridikia Breakdown of academic impact, for papers by Lile He Breakdown of academic impact, for papers by Suan Sun Breakdown of academic impact, for papers by Izabela Sacewicz‐Hofman Breakdown of academic impact, for papers by Dongli Zhao Breakdown of academic impact, for papers by Jiantao Xiao Breakdown of academic impact, for papers by Ching‐Wen Lin Breakdown of academic impact, for papers by Siyang Dong Breakdown of academic impact, for papers by Weijie Dai
Rankless by CCL
2026